NanoVibronix, Inc.

Equities

NAOV

US63008J6038

Medical Equipment, Supplies & Distribution

Market Closed - Nasdaq Other stock markets 21:30:00 17/07/2024 BST			5-day change	1st Jan Change
0.7755 ^USD	-0.84%		+8.46%	-32.57%

05-22	NanoVibronix, Inc. Announces Commencement of UroShield Clinical Study at the University of Michigan	CI
05-15	NanoVibronix, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI

NanoVibronix Files Three U.S. Patent Applications Further Leveraging Its Innovative Surface Acoustic Wave Technology

January 19, 2022 at 01:30 pm

NanoVibronix In announced it has filed three U.S. patent applications with the U.S. Patent & Trademark Office related to its SAW technology and indwelling medical devices to protect targeted new product launches and improvements to existing medical devices.

Latest news about NanoVibronix, Inc.

NanoVibronix, Inc. Announces Commencement of UroShield Clinical Study at the University of Michigan	05-22	CI
NanoVibronix, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	05-15	CI
NanoVibronix Signs Multiyear Distribution Deal With CB Medical for UroShield	05-14	MT
NanoVibronix, Inc. Announces Distribution Agreement with Cb Medical, Llc for the Distribution of Uroshield	05-14	CI
NanoVibronix Announces PainShield Will Be Included in Department of Veteran Affairs? FSS Contract Award	05-01	CI
NanoVibronix, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	04-08	CI
NanoVibronix, Inc. Enters into Letter of Intent with APOGEPHA Arzneimittel GmbH to Explore European Distribution Opportunity	12-04	CI
NanoVibronix, Inc. Signs Research Agreement for Clinical Study of UroShield with University of Michigan	11-28	CI
NanoVibronix, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	11-13	CI
Investors Eye Fed Moves as US Futures Trend Lower in Friday's Premarket	20/10/23	MT
NanoVibronix, Inc. Gains Approval for Inclusion of UroShield Products in NHS Prescription Services' Drug Tariff	27/09/23	CI
NanoVibronix Files Registration Statement on Behalf of Selling Shareholders	13/09/23	MT
NanoVibronix to Raise $5 Million Through Securities Placement	30/08/23	MT
Top Midday Gainers	30/08/23	MT
NanoVibronix, Inc. announced that it expects to receive $5 million in funding	29/08/23	CI
NanoVibronix Says It's Working to Understand Implications of CMS Decision Related to PainShield Device	29/08/23	MT
NanoVibronix, Inc. Applies for Inclusion of Uroshield Products in Nhs Prescription Services' Drug Tariff	28/08/23	CI
NanoVibronix Extends Distribution Agreement With Ultra Pain Products for Ultrasound Therapy Devices; Shares Rise	23/08/23	MT
NanoVibronix Extends Distribution Agreement with Its Largest Distributor for PainShield and PainShield Plus	23/08/23	CI
NanoVibronix, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	11/08/23	CI
NanoVibronix Announces Distribution Agreement with Mio-Guard	14/06/23	CI
NanoVibronix, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	15/05/23	CI
NanoVibronix, Inc. Reports Earnings Results for the Full Year Ended December 31, 2022	17/04/23	CI
NanoVibronix, Inc. Receives Positive Final Results of Independent Lifecycle Testing of PainShield Prompted by Centers for Medicare and Medicaid Services	28/03/23	CI
NanoVibronix Files Provisional Patent Application in US for UroShield Ultra; Shares Jump	21/03/23	MT

Chart NanoVibronix, Inc.

Duration

Period

More charts

Company Profile

NanoVibronix, Inc. is a medical device company. The Company develops medical devices utilizing its patented low intensity surface acoustic wave technology. Its products include UroShield and PainShield. UroShield is an ultrasound-based product that is designed to prevent bacterial colonization and biofilm in urinary catheters, increase antibiotic efficacy and decrease pain and discomfort associated with urinary catheter use. UroShield Ultra is similar to UroShield, but is designed to prevent bacterial colonization and biofilm formation in urinary catheters. PainShield is a patch-based therapeutic ultrasound technology to treat pain, muscle spasm and joint contractures by delivering a localized ultrasound effect to treat pain and induce soft tissue healing in a targeted area. Its PainShield family of products includes PainShield MD, PainShield Plus and WoundShield. WoundShield is a patch-based therapeutic ultrasound device intended to facilitate tissue regeneration and wound healing.

Sector

Medical Equipment, Supplies & Distribution

More about the company

Income Statement Evolution

More financial data

Sector Other Medical Equipment, Supplies & Distribution

	1st Jan change	Capi.
NANOVIBRONIX, INC.	-32.57%	2.16M
ABBOTT LABORATORIES	-4.90%	182B
MEDTRONIC PLC	-1.36%	104B
DEXCOM, INC.	-7.64%	45.58B
HOYA CORPORATION	+9.30%	46.44B
CENCORA, INC.	+9.63%	44.34B
METTLER-TOLEDO INTERNATIONAL, INC.	+13.63%	29.44B
TERUMO CORPORATION	+20.29%	26.8B
WEST PHARMACEUTICAL SERVICES, INC.	-7.12%	23.82B
STERIS PLC	+4.03%	22.61B

Other Medical Equipment, Supplies & Distribution